<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lung transplantation: Anesthetic management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lung transplantation: Anesthetic management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Lung transplantation: Anesthetic management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rebecca M Gerlach, MD, FRCPC</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael F O'Connor, MD, FCCM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 12, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3005384043"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Over 4000 lung transplants are performed annually in the United States after increasing steadily for the past decade  (<a class="graphic graphic_figure graphicRef71574" href="/d/graphic/71574.html" rel="external">figure 1</a>). This topic will discuss anesthetic and pain management for lung transplantation, including unique aspects of this thoracic surgical procedure. General considerations for anesthetic management of open thoracic surgical procedures and one lung ventilation are discussed in other topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14945.html" rel="external">"One lung ventilation: General principles"</a> and  <a class="medical medical_review" href="/d/html/14944.html" rel="external">"Lung isolation techniques"</a>.)</p><p></p><p>Preanesthetic consultation and preparations for lung transplantation are discussed in a separate topic. (See  <a class="medical medical_review" href="/d/html/131415.html" rel="external">"Lung transplantation: Preanesthetic consultation and preparation"</a>.)</p><p>Guidelines for selection of recipients, specific surgical techniques, and postoperative medical and surgical management are discussed in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4659.html" rel="external">"Lung transplantation: An overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management"</a>.)</p><p></p><p class="headingAnchor" id="H871733180"><span class="h1">OVERVIEW OF SURGICAL TECHNIQUES</span><span class="headingEndMark"> — </span>Anesthetic management is determined in part by whether the patient will have a single lung transplant, bilateral lung transplant, or heart-lung transplantation. This decision is made by the surgeon and lung transplantation team based on the patient's underlying disease [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure"</a> and  <a class="medical medical_review" href="/d/html/3525.html" rel="external">"Heart-lung transplantation in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Single lung transplantation </strong>– Single lung transplantation accounts for approximately 25 percent of adult lung transplant procedures  (<a class="graphic graphic_figure graphicRef71574" href="/d/graphic/71574.html" rel="external">figure 1</a>). Indications for single versus bilateral lung transplantation are discussed separately. (See  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Single lung transplantation'</a> and  <a class="medical medical_review" href="/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure"</a>.)</p><p></p><p class="bulletIndent1">Single lung transplantation is accomplished with the patient in lateral position on the operating table  (<a class="graphic graphic_figure graphicRef106622" href="/d/graphic/106622.html" rel="external">figure 2</a>), via a standard posterolateral or anterolateral thoracotomy incision on the selected side. (See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Positioning'</a> and  <a class="medical medical_review" href="/d/html/94593.html" rel="external">"Patient positioning for surgery and anesthesia in adults", section on 'Lateral decubitus'</a>.)</p><p></p><p class="bulletIndent1">One lung ventilation (OLV) is necessary during resection of the lung that will be replaced, unless full cardiopulmonary bypass (CPB) support has been established (see  <a class="medical medical_review" href="/d/html/14945.html" rel="external">"One lung ventilation: General principles"</a> and  <a class="medical medical_review" href="/d/html/14944.html" rel="external">"Lung isolation techniques"</a>). Although no lung ventilation is necessary during full CPB, ventilation of the nonoperative lung is typically necessary when partial mechanical cardiorespiratory support with venoarterial (VA) or venovenous (VV) extracorporeal membrane oxygenation (ECMO) is employed, in order to oxygenate the residual pulmonary blood flow traversing that lung before it mixes with the ECMO blood flow. Furthermore, mechanical ventilation is typically continued to minimize nonoperative lung atelectasis. (See  <a class="medical medical_review" href="/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a>.)</p><p></p><p class="bulletIndent1">In patients receiving VA ECMO support via femoral cannulae (see <a class="local">'Intraoperative venoarterial ECMO support'</a> below), the location of this "mixing point" may be within the aortic arch. In such cases, blood flowing to the head and arms may not be fully oxygenated since it is primarily from the patient's own ventilated (and often diseased) nonoperative lung, even though the lower body receives fully oxygenated blood from the ECMO circuit. Thus, there is often a discrepancy in blood oxygenation for the upper versus the lower body (ie, a differential hypoxemia, also termed "north-south syndrome," or "harlequin syndrome"). Notably, north-south syndrome does not occur with VV ECMO since VV ECMO oxygenates venous blood before it enters the pulmonary circulation; thus, the mixing point occurs in the right atrium (RA) (see <a class="local">'Intraoperative venovenous (VV) ECMO support'</a> below). Counterintuitively, north-south syndrome is worse when cardiac function is better during VA ECMO since ejection of deoxygenated blood from the heart pushes the mixing point distally in the aorta. Options for treatment of this differential hypoxemia include [<a href="#rid2">2</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reducing native cardiac output through infusion of a beta blocking agent (if cardiac function is hyperdynamic).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Placing an LV vent for cardiac decompression (if cardiogenic pulmonary edema is affecting alveolar gas exchange).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increasing VA ECMO flow to move the mixing point closer to the aortic valve. Increasing VA ECMO flow risks inducing cardiac distension and may cause pulmonary edema and worsen oxygenation [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dividing the arterial outflow cannula with a Y connector and providing oxygenated blood into the venous system prior to the pulmonary circulation (called veno-arterial-venous ECMO) can improve systemic oxygenation; however, this requires careful monitoring and adjustment of diverted arterial flows [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1">Even if CPB support is not planned, personnel and equipment for CPB support remain on standby for the duration of a lung transplantation procedure so that CPB can be initiated immediately to assist in the management of refractory hypoxemia, intractable hemodynamic instability, or severe bleeding due to difficulty with surgical dissection (see <a class="local">'Use of cardiopulmonary bypass'</a> below). For example, patients who initially tolerate OLV may experience severe right ventricular (RV) dysfunction and hemodynamic instability at the time of clamping of the pulmonary artery (PA) in preparation for lung resection. PA clamping significantly increases pulmonary artery pressure (PAP) since all cardiac output is suddenly diverted through the vasculature of a single lung. Some patients with pre-existing pulmonary hypertension do not tolerate PA clamping without mechanical cardiorespiratory support with ECMO or full CPB [<a href="#rid5">5</a>]. Furthermore, patients who initially tolerate PA clamping may require cardiorespiratory support later in the procedure (eg, when the left atrium is partially clamped to complete the pulmonary vein anastomoses or at the time of reperfusion of the newly transplanted lung. (See <a class="local">'Mechanical cardiorespiratory support'</a> below and  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Extracorporeal life support'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bilateral lung transplantation </strong>– Bilateral lung transplantation is performed in approximately 75 percent of adult patients  (<a class="graphic graphic_figure graphicRef71574" href="/d/graphic/71574.html" rel="external">figure 1</a>) and is required in those with generalized bronchiectasis (eg, cystic fibrosis) [<a href="#rid6">6</a>], chronic pulmonary infection, or significant pulmonary hypertension  (<a class="graphic graphic_figure graphicRef71574" href="/d/graphic/71574.html" rel="external">figure 1</a>). Patients with other indications also frequently receive bilateral lung transplants due to improved long-term outcomes in some patient groups. (See  <a class="medical medical_review" href="/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure"</a>.)</p><p></p><p class="bulletIndent1">During bilateral lung transplantation, the lungs are implanted separately but sequentially [<a href="#rid7">7</a>]. The standard approach is a bilateral sequential operation through a transverse thoracosternotomy (ie, clamshell) incision  (<a class="graphic graphic_figure graphicRef90511" href="/d/graphic/90511.html" rel="external">figure 3</a>) [<a href="#rid7">7</a>]. The patient is supine, and bilateral submammary incisions are made with transection of the sternum, allowing for complete visualization of the lungs and heart. An alternative bilateral antero-axillary thoracotomy approach that does not transect the sternum is preferred in some centers. Another surgical approach is via a classic sternotomy, but this incision does not provide ideal visualization. (See  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Bilateral lung transplantation'</a>.)</p><p></p><p class="bulletIndent1">After the chest is opened, both native lungs are mobilized. The native lung with the worst function (as previously assessed by ventilation/perfusion scan) is replaced first, while OLV is used for the contralateral lung. Following a brief period of reperfusion of the first lung allograft, OLV switches to the opposite side and the second lung is implanted. With the respiratory support provided by unilateral lung ventilation during bilateral lung transplantation, some patients can avoid mechanical cardiorespiratory support throughout the surgical procedure. However, similar to single lung transplantation, problems with hypoxemia or hemodynamic instability during clamping of the PA on either side may necessitate ECMO or full CPB support. (See  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Extracorporeal life support'</a>.)</p><p></p><p class="headingAnchor" id="H1433394311"><span class="h1">INTRAOPERATIVE ANESTHETIC MANAGEMENT</span><span class="headingEndMark"> — </span>We agree with international consensus recommendations that have been drafted for anesthetic and intensive care management of patients undergoing lung transplantation [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H2084185952"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>Invasive intravascular monitors and a transesophageal echocardiography (TEE) probe are employed during lung transplantation</p><p class="headingAnchor" id="H1592593042"><span class="h3">Invasive intravascular monitors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intra-arterial catheter </strong>– An intra-arterial catheter is placed before induction of general anesthesia since patients scheduled for lung transplantation are susceptible to hypotension during induction due to intravascular volume depletion. Preoperative hypercapnia (partial pressure of carbon dioxide [PaCO<sub>2</sub>] &gt;55 mmHg) predicts development of hypotension with induction [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1">For patients with a radial artery catheter who have a clamshell incision, cephalad retraction of the chest wall during surgery can compress the subclavian artery against the first rib; in such cases the femoral arterial pressure can be 10 to 20 mmHg higher than the radial arterial pressure for the duration of the retraction. If radial arterial pressure readings are suspected to be inaccurate, intraoperative hypotension can be confirmed either by checking noninvasive blood pressure measurements using a cuff on the contralateral arm, or by placing a femoral arterial line.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Large-bore central venous catheter </strong>– Since most patients require administration of intravenous (IV) vasopressors and inotropes, and may need extracorporeal membrane oxygenation (ECMO) or full cardiopulmonary bypass (CPB), a large-bore central venous catheter (CVC) is always inserted, typically after induction of general anesthesia. For most patients, we prefer a 9 Fr double-lumen introducer placed in the right internal jugular (IJ) vein. A subclavian CVC site is less desirable due to a higher risk of pneumothorax during insertion, and the catheter may become obstructed during retraction of the chest wall.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary artery catheter </strong>– A pulmonary artery catheter (PAC) is also inserted, typically after induction, in order to monitor pulmonary artery pressure (PAP) throughout the perioperative period [<a href="#rid10">10</a>]. The surgeon must be aware of the position of the PAC before transecting the pulmonary artery (PA) in order to avoid entrapment of the catheter tip. Using TEE (midesophageal ascending aorta short-axis view) to position the PAC tip within the main PA before its bifurcation aids in avoiding this complication.</p><p></p><p class="headingAnchor" id="H3533818524"><span class="h3">Transesophageal echocardiography</span><span class="headingEndMark"> — </span>TEE is routinely employed during single or bilateral lung transplantation for initial evaluation of cardiovascular anatomy and function and subsequent continuous intraoperative monitoring [<a href="#rid11">11-17</a>]. The etiology of systemic hypotension can be rapidly assessed and appropriately managed with vasopressor therapy (primarily) and/or volume administration during periods of hemodynamic instability.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intravascular volume assessment</strong> – Assessment of intravascular volume status and left ventricular (LV) filling is helpful to guide fluid therapy throughout the intraoperative period. Inadequate LV filling can be quickly assessed in the transgastric midpapillary short-axis view using qualitative visual assessment of LV cavity size. Also, quantitative measurements of the internal diameter or cross-sectional area of the LV at end-diastole can be made. These qualitative and/or quantitative assessments allow recognition of changes from baseline. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Assessment of left ventricular volume'</a>.)</p><p></p><p class="bulletIndent1">These assessments are particularly valuable during periods of hypotension. Although maintaining a restrictive fluid strategy is important for postoperative pulmonary graft function (see <a class="local">'Fluid and transfusion management'</a> below), this may lead to hypotension, particularly in hypovolemic patients. Other causes of inadequate LV filling can also be recognized using TEE, including acute right ventricular (RV) dysfunction or systemic vasodilation occurring after lung reperfusion, which can also cause dynamic LV outflow tract obstruction [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Right ventricular function </strong>–<strong> </strong>RV function is assessed throughout the procedure [<a href="#rid10">10,16,17</a>]. Increased RV end-diastolic volume, decreased RV free-wall endocardial excursion and wall thickening, LV septal displacement, and decreased tricuspid annular plane systolic excursion are some of the most commonly observed signs of RV overload and dysfunction  (<a class="graphic graphic_movie graphicRef105882" href="/d/graphic/105882.html" rel="external">movie 1</a>) [<a href="#rid18">18</a>]. Details regarding a comprehensive TEE assessment of RV function are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/83974.html" rel="external">"Echocardiographic assessment of the right heart"</a>.)</p><p></p><p class="bulletIndent1">Development of severe RV dysfunction influences intraoperative decisions to initiate mechanical cardiorespiratory support (eg, ECMO or full CPB), particularly during PA clamping if hypoxemia and/or hemodynamic instability are refractory to inotropic agents and pulmonary vasodilators [<a href="#rid10">10,19</a>]. (See <a class="local">'Mechanical cardiorespiratory support'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Left ventricular function </strong>– LV dysfunction may occur due to coronary air embolism following reperfusion of the transplanted lung if de-airing of the graft is incomplete. Most commonly, inferior regional wall motion abnormality and RV dysfunction occurs due to air embolism to the right coronary artery. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Regional LV systolic function'</a>.)</p><p></p><p>Intraoperative TEE is also used to:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Guide ECMO cannula placement </strong>– TEE is typically employed in patients requiring intraoperative ECMO  (<a class="graphic graphic_figure graphicRef56622" href="/d/graphic/56622.html" rel="external">figure 4</a> and <a class="graphic graphic_diagnosticimage graphicRef116518" href="/d/graphic/116518.html" rel="external">image 1</a>) [<a href="#rid19">19</a>]. (See <a class="local">'Intraoperative venovenous (VV) ECMO support'</a> below and <a class="local">'Intraoperative venoarterial ECMO support'</a> below.)</p><p></p><p class="bulletIndent1">TEE can be used to guide placement of a venous cannula into the right atrium (RA) without abutting the tricuspid valve or interatrial septum [<a href="#rid16">16</a>]. Successful guidewire cannulation for the arterial cannula is confirmed by visualization of a wire in the descending aorta, with proper final positioning of an arterial cannula in the descending aorta sometimes possible, depending on cannula length. Furthermore, poor venous return due to hypovolemia or complications caused by an ECMO cannula (eg, kinking, obstruction, perforation of the interatrial septum) can often be diagnosed with TEE [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assess post-transplant pulmonary vein anastomoses</strong> – Post-transplant assessment of pulmonary vein (PV) anastomoses is important to rule out any restriction of blood flow through these vessels since this may lead to postoperative pulmonary edema, hypoxia, and lung graft failure [<a href="#rid14">14,16,20-22</a>]. PV flow may be restricted due to kinking, external compression, sutures, or thrombus in the PV [<a href="#rid12">12,21,22</a>]. Poor gas exchange and allograft engorgement suggest significant PV obstruction [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1">Flow from all four PVs should be examined with both color-flow and pulsed-wave Doppler  (<a class="graphic graphic_diagnosticimage graphicRef122716" href="/d/graphic/122716.html" rel="external">image 2</a>). Flow should appear laminar (nonturbulent), with peak velocity &lt;100 cm/second  (<a class="graphic graphic_movie graphicRef122717" href="/d/graphic/122717.html" rel="external">movie 2</a>). However, velocities may be transiently higher after single lung implantation when blood flow is disproportionately diverted through the new lung allograft due to its lower pulmonary vascular resistance (PVR).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assess post-transplant pulmonary artery anastomoses</strong> – Post-transplant assessment of both pulmonary artery (PA) anastomoses is also important to rule out stenosis [<a href="#rid21">21</a>]. The TEE midesophageal ascending aorta short axis view is best for visualizing the main PA and right PA. The left PA may be difficult to visualize by TEE due to proximity to the left main bronchus.</p><p></p><p class="bulletIndent1">Two-dimensional assessment of each PA anastomosis should note a diameter that is ≥75 percent of the ipsilateral native PA [<a href="#rid12">12,21</a>]. Doppler assessment of each PA anastomosis is also necessary to rule out turbulent flow or a significant gradient across the anastomosis indicating possible stenosis.</p><p></p><p class="headingAnchor" id="H3192937176"><span class="h2">Induction and intubation</span></p><p class="headingAnchor" id="H2627811475"><span class="h3">Induction of general anesthesia</span><span class="headingEndMark"> — </span>If a rapid sequence induction and intubation (RSII) is planned because of insufficient fasting time, induction agents and doses are selected based in part on the potential for hemodynamic instability. Even if ventricular function is normal, patients with severe pulmonary hypertension or poor lung compliance requiring high ventilation pressures are sensitive to the sudden reductions in preload that may occur during anesthetic induction [<a href="#rid5">5</a>]. For this reason, we typically choose <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> 0.2 to 0.3 mg/kg to minimize likelihood of hemodynamic instability during anesthetic induction with planned RSII. (See  <a class="medical medical_review" href="/d/html/131415.html" rel="external">"Lung transplantation: Preanesthetic consultation and preparation", section on 'Determination of fasting status'</a> and  <a class="medical medical_review" href="/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia"</a> and  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Etomidate'</a>.)</p><p>In patients without aspiration risk factors, a combination of anesthetic and adjuvant agents may be used to achieve a slower induction. For example, a low dose of a short-acting benzodiazepine (eg, <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> 1 to 4 mg) plus a moderate dose of synthetic opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 2 to 4 mcg/kg or <a class="drug drug_general" data-topicid="9954" href="/d/drug information/9954.html" rel="external">sufentanil</a> 0.2 to 0.5 mcg/kg) plus a reduced dose of the selected sedative-hypnotic induction agent (eg, <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> 0.5 to 1 mg/kg or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> 0.5 to 2 mg/kg or <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> 0.2 mg/kg) may be administered. Propofol is the most commonly selected sedative-hypnotic anesthetic induction agent for lung transplant recipients since adrenal suppression during subsequent postoperative care is not a risk as it may be with etomidate [<a href="#rid5">5,13</a>]. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents"</a>.)</p><p>A variety of vasoactive agents should be readily available  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 1</a>), since hemodynamic instability may occur during or immediately after induction, even in patients with normal ventricular function.</p><p class="headingAnchor" id="H3619316552"><span class="h3">Lung isolation</span><span class="headingEndMark"> — </span>Lung isolation is usually with double-lumen endotracheal tube (DLT) placement [<a href="#rid13">13</a>]. During single lung transplantation, a left-sided DLT is selected for right pneumonectomy  (<a class="graphic graphic_figure graphicRef88677" href="/d/graphic/88677.html" rel="external">figure 5</a>), while a right-sided DLT is selected for left pneumonectomy  (<a class="graphic graphic_figure graphicRef88676" href="/d/graphic/88676.html" rel="external">figure 6</a>). For bilateral lung transplantation, a left-sided DLT is usually selected due to ease of use. In this case, the bronchial cuff of the left-sided DLT is positioned as far proximally as possible to allow room for the anastomosis. The cuff remains inflated in the left mainstem bronchus during the left bronchial anastomosis to avoid a large air-leak into the surgical field. (See  <a class="medical medical_review" href="/d/html/14944.html" rel="external">"Lung isolation techniques", section on 'Double-lumen endobronchial tubes'</a> and  <a class="medical medical_review" href="/d/html/14944.html" rel="external">"Lung isolation techniques", section on 'Left pneumonectomy or bronchial surgery'</a>.)</p><p>A bronchial blocker placed through a single-lumen tube may be selected (rather than a DLT) if the patient has anticipated or actual difficulty with intubation. However, bronchial blockers are vulnerable to dislodgement during manipulation of the mainstem bronchus. Also, in rare cases, a bronchial blocker or its guidewire has become entrapped in the surgical staple line along the left bronchial stump during lung resection surgery [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/14944.html" rel="external">"Lung isolation techniques", section on 'Bronchial blockers'</a>.)</p><p class="headingAnchor" id="H334049435"><span class="h2">Maintenance of anesthesia</span><span class="headingEndMark"> — </span>We typically use the potent volatile inhalation agent <a class="drug drug_general" data-topicid="9887" href="/d/drug information/9887.html" rel="external">sevoflurane</a> for maintenance of general anesthesia, and we administer a nondepolarizing neuromuscular blocking agent. We also administer bolus doses of an IV opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a>, <a class="drug drug_general" data-topicid="9954" href="/d/drug information/9954.html" rel="external">sufentanil</a>), while some centers employ an infusion of sufentanil, <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>, or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> infusion. However, regional variations in techniques to maintain anesthesia during lung transplantation are common. For example, many European transplant centers avoid inhalation anesthetic agents and use a total IV anesthetic technique instead [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/96308.html" rel="external">"Maintenance of general anesthesia: Overview"</a>.)</p><p class="headingAnchor" id="H31787414"><span class="h2">Ventilation before transplantation</span><span class="headingEndMark"> — </span>Transitioning from spontaneous breathing to positive pressure ventilation during induction and subsequently transitioning to one lung ventilation (OLV) at the time of lung resection is often challenging in a patient with severe lung disease.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Two lung ventilation after intubation </strong>– After intubation, low tidal volume (TV) ventilation is initiated at approximately 6 mL/kg (predicted body weight) during two lung ventilation. The respiratory rate is adjusted to maintain the end-tidal carbon dioxide (ETCO<sub>2</sub>) and PaCO<sub>2</sub> near baseline. Although guidelines for low TV ventilation in patients with acute respiratory distress syndrome are clearly established  (<a class="graphic graphic_table graphicRef57072" href="/d/graphic/57072.html" rel="external">table 2</a>), adjustments are often needed to achieve adequate ventilation and oxygenation during the operative period. (See  <a class="medical medical_review" href="/d/html/14945.html" rel="external">"One lung ventilation: General principles", section on 'Lung-protective ventilation strategies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Changing to one lung ventilation </strong>– Prior to initiating OLV, patients are ventilated with an FiO<sub>2</sub> of 100 percent to minimize subsequent desaturation and promote absorption atelectasis in the non-ventilated lung, thereby decreasing shunt. After switching to OLV, the TV is typically decreased to approximately 4 to 5 mL/kg. The fraction of inspired oxygen (FiO<sub>2</sub>) is adjusted, aiming for a pulse oxygen saturation (SpO<sub>2</sub>) of 89 to 95 percent. However, oxygenation of the native single lung is frequently very poor so that titration of FiO<sub>2</sub> below 100 percent is not possible.</p><p></p><p>During either two lung or one lung ventilation, lung transplant patients are at risk for barotrauma caused by elevated ventilation pressures, with the potential consequences of tension pneumothorax when the chest is closed or a large air leak after the chest is open. Maintaining small TV with pressure-controlled ventilation reduces risk of barotrauma. However, providing a minute ventilation that is too low will worsen hypercarbia, which may worsen pulmonary hypertension and RV dysfunction. Even small increases in ETCO<sub>2</sub> may produce a measurable rise in PVR [<a href="#rid24">24</a>]. Additional details of OLV and an approach to the management of hypoxemia are provided separately. (See  <a class="medical medical_review" href="/d/html/14945.html" rel="external">"One lung ventilation: General principles"</a> and  <a class="medical medical_review" href="/d/html/14944.html" rel="external">"Lung isolation techniques"</a>.)</p><p>During either two lung or one lung ventilation, the target for plateau inspiratory pressure should be &lt;30 cm H<sub>2</sub>O [<a href="#rid10">10,13</a>]. Positive end-expiratory pressure (PEEP) is usually set at 5 to 10 cm H<sub>2</sub>O. Notably, higher PEEP levels may decrease preload and cause hypotension in an anesthetized, vasodilated patient undergoing lung transplantation. Prolonging the expiratory time (eg, inspiratory to expiratory [I:E] ratio) to a ratio of 1:3 or 1:4 for patients with chronic obstructive pulmonary disease (COPD; or other pulmonary conditions that impair expiratory flow rate) helps reduce air trapping by allowing sufficient exhalation time, although a high inspiratory flow (needed to shorten inspiratory time) may increase peak inspiratory pressures. Inadequate time for exhalation leads to breath-stacking with increased intrathoracic pressure and decreased venous return, which can lead to profound hypotension. Hypotension due to such dynamic hyperinflation (also termed auto-PEEP, intrinsic-PEEP, or gas-trapping) is treated by disconnecting the ventilator and allowing the patient to exhale fully. (See  <a class="medical medical_review" href="/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Ventilator settings'</a> and  <a class="medical medical_review" href="/d/html/1459.html" rel="external">"Dynamic hyperinflation in patients with COPD"</a>.)</p><p class="headingAnchor" id="H3186627497"><span class="h2">Antibiotic prophylaxis and immunosuppression</span><span class="headingEndMark"> — </span>Since immunosuppression places lung transplant recipients at high risk for opportunistic bacterial infections, broad-spectrum antibiotic prophylaxis is initiated prior to surgical incision. Examples are given in the table  (<a class="graphic graphic_table graphicRef78763" href="/d/graphic/78763.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/1395.html" rel="external">"Bacterial infections following lung transplantation", section on 'Routine perioperative prophylaxis'</a> and  <a class="medical medical_review" href="/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.)</p><p>Adherence to the prescribed plan for immunosuppression is critical to prevent allograft rejection and preserve lung function. A bolus of <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a> (500 to 1000 mg) is administered in the intraoperative period immediately prior to reperfusion of each graft when the PA clamp is released. Additional induction immunosuppression therapy may be administered during the intraoperative or early postoperative period according to institutional protocol. These agents can be classified into two groups: monoclonal antibody preparations (eg, <a class="drug drug_general" data-topicid="8803" href="/d/drug information/8803.html" rel="external">basiliximab</a>) and polyclonal agents (eg, anti-lymphocyte and anti-thymocyte globulins). One example of an early initiation regimen includes basiliximab 20 mg administered as an IV infusion over 30 minutes and IV <a class="drug drug_general" data-topicid="9670" href="/d/drug information/9670.html" rel="external">mycophenolate</a> 1000 mg infused over two hours in the operating room (OR), with both agents initiated at the beginning of the operation. (See  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Initiation of immunosuppression'</a> and  <a class="medical medical_review" href="/d/html/4661.html" rel="external">"Induction immunosuppression following lung transplantation"</a>.)</p><p class="headingAnchor" id="H3849201711"><span class="h2">Mechanical cardiorespiratory support</span><span class="headingEndMark"> — </span>In approximately 20 to 40 percent of patients, either ECMO or full CPB is necessary to complete lung transplantation, although use varies widely among centers [<a href="#rid13">13,19,25-30</a>]. Patients who will most likely need ECMO or CPB include those with severe primary pulmonary hypertension with a transpulmonary pressure gradient &gt;20 mmHg, pulmonary fibrosis, or RV dysfunction with hypertrophy or dilation [<a href="#rid5">5,25-27,29</a>]. We and many other centers favor use of ECMO rather than CPB when possible, based on observational studies indicating that ECMO support is associated with lower rates of primary graft dysfunction (PGD), need for dialysis, tracheostomy, or blood transfusion, and shorter intubation time and hospital stay [<a href="#rid25">25-31</a>].</p><p class="headingAnchor" id="H1120887689"><span class="h3">Intraoperative venovenous (VV) ECMO support</span><span class="headingEndMark"> — </span>Management of patients who require venovenous (VV) ECMO support in the preoperative period before lung transplantation is discussed separately. (See  <a class="medical medical_review" href="/d/html/131415.html" rel="external">"Lung transplantation: Preanesthetic consultation and preparation", section on 'Preoperative extracorporeal membrane oxygenation'</a>.)</p><p>If VV ECMO was initiated in the preoperative period and is being maintained when the patient enters the OR, the ECMO circuit monitor is positioned within view of the anesthesiologist for assessment of device function, flow, and pump speed. Dual-stage cannulae for VV ECMO that were placed via the right IJ vein depend on maintaining an appropriate position in order to function properly  (<a class="graphic graphic_figure graphicRef121601" href="/d/graphic/121601.html" rel="external">figure 7</a>). Desaturation while on VV ECMO may indicate malposition of the cannula or other causes of inadequate ECMO flow. Excess cannula rotation or retraction can cause the outflow port to become misaligned with the tricuspid valve, leading to ineffective flow of oxygenated blood into the RV. Thus, caution is necessary to avoid excessive manipulation of the cannula during head positioning for endotracheal intubation or central line placement in the left IJ or left subclavian vein. Furthermore, PAC placement may be challenging due to obstruction from VV ECMO cannulae. TEE guidance is used to assist PAC placement. (See  <a class="medical medical_review" href="/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)", section on 'Monitoring during ECMO support'</a>.)</p><p>In some cases, the surgeon may insert a bicaval dual-lumen cannula via the right IJ vein during the preoperative period as access for ECMO support [<a href="#rid32">32,33</a>]. In other cases, the surgeon may plan intraoperative insertion of a dual-lumen VV ECMO cannula, so the anesthesiologist must avoid placement of a standard CVC in the right IJ. In such cases, alternative sites for placement of the CVC include left IJ or left subclavian vein.</p><p>The anesthesiology team typically provides assistance with insertion of cannulae for initiation of ECMO support via TEE imaging, particularly if a dual-lumen cannula is used  (<a class="graphic graphic_figure graphicRef121601" href="/d/graphic/121601.html" rel="external">figure 7</a>). This dual-lumen cannula is highly dependent on positioning for adequate function. Also, any migration of this catheter may result in systemic hypoxemia if the outflow port is no longer positioned to provide adequate flow across the tricuspid valve. (See  <a class="medical medical_review" href="/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)", section on 'Central cannulation'</a>.)</p><p>If urgent intraoperative initiation of VV ECMO becomes necessary to treat refractory hypoxia during transition to OLV, clamping of the PA, partial clamping of the left atrium during PV anastomosis, or during reperfusion of the newly transplanted lung, this can be accomplished using femoral vein to femoral vein VV ECMO [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)", section on 'Peripheral cannulation'</a>.)</p><p class="headingAnchor" id="H3614229794"><span class="h3">Intraoperative venoarterial ECMO support</span><span class="headingEndMark"> — </span>Venoarterial (VA) is usually preferred for intraoperative cardiopulmonary support, rather than CPB [<a href="#rid5">5</a>]. If peripheral VA ECMO is needed during the intraoperative period due to anticipated or actual hemodynamic instability, the anesthesiology team typically provides assistance with TEE imaging during insertion of cannulae for initiation of ECMO support. Femoral vein to a femoral artery or to the right subclavian artery or central VA ECMO (RA to ascending aorta) can be established electively [<a href="#rid17">17,34,35</a>], or as an emergency if hemodynamic compromise occurs during lung transplant without full CPB support  (<a class="graphic graphic_figure graphicRef121745" href="/d/graphic/121745.html" rel="external">figure 8</a>) [<a href="#rid17">17,19,25,26</a>]. Although peripheral VA ECMO is associated with increased rates of groin vascular complications, it is the preferred technique when ECMO support is likely to be continued postoperatively [<a href="#rid36">36</a>]. An additional cannula is often used to provide oxygenated blood to the cannulated leg to avoid distal ischemia from obstructed blood flow  (<a class="graphic graphic_figure graphicRef121745" href="/d/graphic/121745.html" rel="external">figure 8</a>). (See  <a class="medical medical_review" href="/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)", section on 'Cannula insertion and initiation'</a>.)</p><p class="headingAnchor" id="H530150100"><span class="h3">Use of cardiopulmonary bypass</span><span class="headingEndMark"> — </span>CPB is sometimes established electively prior to starting lung resection in patients with severe pulmonary hypertension, particularly if there is concern regarding RV function. As in typical CPB for cardiac surgery  (<a class="graphic graphic_figure graphicRef97188" href="/d/graphic/97188.html" rel="external">figure 9</a>), venous cannulation may be accomplished with a single dual-stage venous cannula placed via the appendage of the RA with the distal tip of the cannula positioned in the inferior vena cava or with bicaval separate cannulation of the superior vena cava and the inferior vena cava. Aortic cross clamping and cardiac arrest with cardioplegia are not necessary to perform lung transplantation on CPB unless concomitant intracardiac procedures or major atrial reconstruction are planned. (See  <a class="medical medical_review" href="/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass", section on 'Venous cannulation'</a>.)</p><p class="headingAnchor" id="H4124784539"><span class="h2">Anticoagulation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>No mechanical cardiorespiratory support </strong>– Anticoagulation during lung transplant without full CPB support is managed with 5000 units of IV heparin administered prior to vascular occlusion. Heparin is typically redosed prior to a second lung transplant on the contralateral side. The decision to reverse heparin with protamine is made by assessing the degree of ongoing bleeding and considering the potential adverse effects of protamine administration including an increase in PVR. Since the heparin dose is low, protamine reversal is often omitted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extracorporeal membrane oxygenation</strong> – Either VV ECMO or VA ECMO requires some level of anticoagulation, although less than the systemic dose required for full CPB. Typically, a single dose of IV heparin 5000 units is administered to initiate either VV ECMO or VA ECMO. Subsequently, the activated clotting time (ACT) is maintained within a range (eg, 180 to 210 seconds) by administering additional doses of heparin or using a heparin infusion [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/1368.html" rel="external">"Clinical use of coagulation tests", section on 'Monitoring heparins'</a>.)</p><p></p><p class="bulletIndent1">If VV ECMO was initiated during the preoperative period, the anticoagulation strategy may vary according to patient-specific and institution-specific factors. For example, a lower ACT target may have been selected for patients with any hemorrhagic complication (eg, epistaxis, cannulation site hematoma, intracranial hemorrhage, gastrointestinal bleeding). At our institution, anticoagulation in the intensive care unit (ICU) is maintained with a continuous infusion of IV heparin, titrated to an ACT of 180 to 210 seconds. Some institutions maintain activated partial thromboplastin time (aPTT) at 45 to 80 seconds, rather than monitoring ACT to manage anticoagulation in the ICU [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1">We turn off this heparin infusion just before patient transport to the OR, so that bleeding will be minimized during the initial dissection phase of the transplantation procedure. During the intraoperative period, small bolus doses of IV heparin (eg 2500 to 5000 units) are administered to achieve the intraoperative target ACT value (eg, 180 to 210 seconds) before beginning lung resection, and this value is maintained throughout the procedure while the patient remains on ECMO.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiopulmonary bypass</strong> – Full systemic anticoagulation is required for patients undergoing CPB. Typically, IV heparin 300 to 400 units/kg is administered, then the ACT is maintained at ≥400 to 480 seconds to prevent clot formation in the CPB circuit. (See  <a class="medical medical_review" href="/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass", section on 'Heparin administration and monitoring'</a>.)</p><p></p><p class="headingAnchor" id="H370505065"><span class="h2">Fluid and transfusion management</span><span class="headingEndMark"> — </span>We use a restrictive fluid management strategy during lung transplantation, similar to other open thoracotomy procedures. Intraoperative administration of large fluid volumes is associated with increased lung interstitial fluid and other extravascular lung water; these may lead to pulmonary edema, prolonged postoperative ventilation, and increased risk of PGD [<a href="#rid38">38-40</a>] (see <a class="local">'Primary graft dysfunction after reperfusion'</a> below). We use crystalloid solution for maintenance fluid, but a colloid (eg, albumin 5%) is administered for volume resuscitation. (See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Fluid and hemodynamic management'</a>.)</p><p>The volume of transfused red blood cells (RBCs) is a risk factor for PGD and mortality after lung transplantation, particularly when massive transfusion (&gt;10 to 15 units) is required. [<a href="#rid40">40-43</a>]. Also, a higher ratio of fresh frozen plasma (FFP) to RBCs (&gt;1:2) during massive transfusion is associated with more severe PGD [<a href="#rid44">44</a>]. In one study, transfusion of &gt;15 units of RBCs was associated with increased mortality risk (hazard ratio [HR] 1.36, CI 1.14-1.6) in patients undergoing lung transplantation [<a href="#rid43">43</a>]. Use of recombinant human activated factor VIIa did not increase mortality risk in this study, but it is unclear whether its use decreases transfusion requirements in this setting.</p><p class="headingAnchor" id="H3905774410"><span class="h2">Hemodynamic management</span><span class="headingEndMark"> — </span>Hypotension is common during lung transplantation, particularly during clamping of the PA, side clamping (ie, partial clamping) of the left atrium to complete the PV anastomoses, and/or reperfusion of the lung. Preemptive treatment with vasopressors, inotropes, or pulmonary vasodilators may prevent the need for emergency mechanical cardiorespiratory support  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 1</a>).</p><p>We use <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> as the first-line vasopressor agent to treat hypotension, as do many other centers  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 1</a>) [<a href="#rid13">13</a>]. If hypotension persists (eg, due to vasoplegic syndrome) [<a href="#rid45">45</a>], we add or substitute <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a> to further increase systemic vascular resistance (SVR). Vasopressin has little effect on PVR [<a href="#rid46">46</a>] and no beta-agonistic effect, which may contribute to its association with reduced atrial fibrillation and other associated adverse outcomes when used to treat postoperative shock [<a href="#rid47">47</a>].</p><p>In patients with severe RV dysfunction or failure, we typically add or substitute <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">dobutamine</a>, or <a class="drug drug_general" data-topicid="9652" href="/d/drug information/9652.html" rel="external">milrinone</a> [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/94362.html" rel="external">"Anesthesia for noncardiac surgery in patients with pulmonary hypertension or right heart failure", section on 'Vasopressors and inotropes'</a> and  <a class="medical medical_review" href="/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass", section on 'Right ventricular dysfunction'</a>.)</p><p>For patients with refractory pulmonary hypertension and RV dysfunction, an inhaled pulmonary vasodilator such as <a class="drug drug_general" data-topicid="9447" href="/d/drug information/9447.html" rel="external">inhaled nitric oxide</a> (iNO) may be added to achieve selective pulmonary vasodilation<em> </em>[<a href="#rid5">5,13,48</a>]. An alternative agent to reduce PVR is inhaled prostanoid (ie, <a class="drug drug_general" data-topicid="9411" href="/d/drug information/9411.html" rel="external">epoprostenol</a>) administered off-label via jet nebulizer [<a href="#rid49">49-51</a>]. However, optimal timing of initiation of pulmonary vasodilator therapy and efficacy of such therapy with respect to outcomes are unclear [<a href="#rid52">52,53</a>]. Therapy is frequently initiated at maximal dose to treat refractory pulmonary hypertension, with little opportunity for intraoperative weaning. Inability to wean off iNO at the end of the procedure is a risk factor for development of PGD [<a href="#rid54">54</a>]. (See <a class="local">'Primary graft dysfunction after reperfusion'</a> below and  <a class="medical medical_review" href="/d/html/94362.html" rel="external">"Anesthesia for noncardiac surgery in patients with pulmonary hypertension or right heart failure", section on 'Chronic targeted therapy for pulmonary hypertension: Patient selection'</a> and  <a class="medical medical_review" href="/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass", section on 'Right ventricular dysfunction'</a>.)</p><p class="headingAnchor" id="H833336705"><span class="h2">Ventilation after lung transplantation</span></p><p class="headingAnchor" id="H486216268"><span class="h3">Single lung transplantation</span></p><p class="headingAnchor" id="H2142688292"><span class="h4">General considerations for lung-protective ventilation</span><span class="headingEndMark"> — </span>After removal of the PA clamp and reperfusion of the transplanted lung, reinflation is accomplished with three to five manual recruitment breaths (eg, sequential inflations/deflations with 30 cm H<sub>2</sub>O for 15 seconds each). A lung-protective ventilation strategy is employed, with low tidal volumes ≤6 mL/kg (based on the donor predicted body weight) to maintain low airway pressures after two lung ventilation has been reestablished [<a href="#rid17">17,55,56</a>]. Notably, peak inspiratory pressures will be lower before chest closure than after the chest is closed. PEEP is typically set at low levels (5 to 10 cm<sub> </sub>H<sub>2</sub>O) and adjusted based on oxygenation. PEEP is used with extreme caution (eg, ≤5 cm<sub> </sub>H<sub>2</sub>O) in patients with COPD who undergo single lung transplantation to avoid overinflation of the more compliant native lung. Respiratory rate is adjusted to maintain adequate minute ventilation. (See <a class="local">'Ventilation before transplantation'</a> above and  <a class="medical medical_review" href="/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Ventilatory support and weaning'</a>.)</p><p>A high inspired oxygen concentration (FiO<sub>2</sub> &gt;40 percent) is avoided during reperfusion of the transplanted lung since this is associated with PGD [<a href="#rid17">17,41,57</a>]. Typically, the lowest FiO<sub>2</sub> that maintains arterial partial pressure of oxygen (PaO<sub>2</sub>) &gt;70 mmHg and noninvasive pulse oximetry measurement of oxygenation (SpO<sub>2</sub>) at 92 percent are targets that avoid reperfusion injury [<a href="#rid17">17,55</a>].</p><p>Notably, there are no standards for an ideal ventilation mode in all patients during the immediate post-transplantation period, or for maximum peak airway pressure, use of PEEP, or FiO<sub>2</sub> [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H2781290773"><span class="h4">Avoid hyperinflation of the native lung</span><span class="headingEndMark"> — </span>Native lung hyperinflation is a phenomenon specific to single lung transplantation performed for severe emphysema, where gas trapping within the native lung can cause mediastinal shift and compression of the transplanted lung with resulting impaired gas exchange and hemodynamic compromise [<a href="#rid59">59</a>]. Persistent native lung hyperinflation prolongs time on the ventilator in the postoperative period [<a href="#rid59">59</a>].</p><p>In the OR, the flow-volume loop or expiratory flow curve on the anesthesia ventilator monitor is examined for ongoing expiratory flow at the start of inspiratory flow (ie, flow rate does not return to zero). This alerts the clinician to possible breath-stacking (also called auto-PEEP or intrinsic-PEEP) and hyperinflation. If present, a biphasic capnography tracing indicates differences in exhalation rate and CO<sub>2</sub> release between the native and transplanted lung  (<a class="graphic graphic_figure graphicRef121122" href="/d/graphic/121122.html" rel="external">figure 10</a>) [<a href="#rid60">60,61</a>]. This phenomenon can be managed by using differential lung ventilation via the DLT during the intraoperative period. In the OR, a second portable ventilator is attached to the DLT lumen directed to the remaining native lung, and asynchronous ventilator settings for the patient’s disease are employed (eg, prolonged expiratory time to avoid breath-stacking, lower TV) [<a href="#rid62">62</a>].</p><p class="headingAnchor" id="H2300415468"><span class="h3">Bilateral lung transplantation</span></p><p class="headingAnchor" id="H1345511944"><span class="h4">After transplantation of the first lung</span><span class="headingEndMark"> — </span>After a period of reperfusion (eg, 15 to 30 minutes), OLV of the transplanted lung is established prior to resection of the second lung. Recruitment breaths and lung-protective ventilation are managed as described for single lung transplantation (see <a class="local">'Single lung transplantation'</a> above). Low TV for single lung ventilation (4 mL/kg), PEEP of 5 to 10 cm H<sub>2</sub>O, and the lowest possible FiO<sub>2</sub> that maintains PaO<sub>2</sub> &gt;70 mmHg and SpO<sub>2</sub> at 92 percent are employed [<a href="#rid55">55</a>].</p><p></p><p class="headingAnchor" id="H2220319222"><span class="h4">After transplantation of the second lung</span><span class="headingEndMark"> — </span>After reperfusion and lung volume recruitment of the second transplanted lung, two lung ventilation is resumed with low TV ventilation (4 to 6 mL/kg), PEEP of 5 to 10 cm H<sub>2</sub>O and the lowest FiO<sub>2</sub> that maintains SpO<sub>2</sub> at 92 percent. If higher (&gt;50 percent) FiO<sub>2</sub> is required, oxygenation may be improved by additional recruitment maneuvers, small increases in PEEP, administration of bronchodilators, or airway suctioning.</p><p>Pressure-controlled ventilation may be selected for some patients, rather than volume control ventilation. In one study of patients undergoing sequential bilateral lung transplantation, an intraoperative ventilation strategy using pressure control ventilation (set at 16 cm H<sub>2</sub>O) with higher PEEP (at 10 cm H<sub>2</sub>O) plus recruitment maneuvers was compared with a strategy using volume control ventilation (TV 4 mL/kg ideal body weight) with lower PEEP (at 5 cm H<sub>2</sub>O) [<a href="#rid63">63</a>]. At 24 postoperative hours, patients in pressure control group with higher PEEP had shorter times to extubation and similar oxygenation parameters. (See  <a class="medical medical_review" href="/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Modes of intraoperative mechanical ventilation'</a> and  <a class="medical medical_review" href="/d/html/1651.html" rel="external">"Modes of mechanical ventilation", section on 'Volume-limited versus pressure-limited'</a>.)</p><p class="headingAnchor" id="H211238059"><span class="h2">Primary graft dysfunction after reperfusion</span><span class="headingEndMark"> — </span>PGD may occur shortly after reperfusion of the transplanted lung and should be suspected in patients with refractory hypoxemia (low PaO<sub>2</sub>/FiO<sub>2</sub> ratio) after inflation and reperfusion of the allograft(s) and exclusion of other sources of poor oxygenation (eg, occlusion of a pulmonary venous anastomosis, pulmonary thromboembolism, mucous plugging, cardiogenic pulmonary edema, aspiration, pneumonia, or antibody-mediated rejection of the donor lung) [<a href="#rid56">56</a>]. The risk of PGD may be increased due to various donor, recipient, and operative risk factors  (<a class="graphic graphic_figure graphicRef57115" href="/d/graphic/57115.html" rel="external">figure 11</a>).</p><p>The severity of PGD is graded based on the PaO<sub>2</sub>/FiO<sub>2 </sub>ratio and the presence or absence of diffuse opacities on the chest radiograph  (<a class="graphic graphic_table graphicRef78107" href="/d/graphic/78107.html" rel="external">table 4</a>) [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/d/html/4663.html" rel="external">"Primary lung graft dysfunction", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/4663.html" rel="external">"Primary lung graft dysfunction", section on 'Diagnostic evaluation'</a>.)</p><p>For patients with refractory hypoxemia despite optimal intravascular volume status and fine-tuning of ventilator settings, a trial of iNO is initiated (typically at 10 to 20 parts per million [ppm]) [<a href="#rid65">65</a>]. For patients with PaO<sub>2</sub>/FiO<sub>2</sub> &lt;100, we start iNO at 20 ppm and wean this dose according to improvements in oxygenation. This is accomplished by weaning iNO from 20 ppm to 5 ppm in decrements of 5 ppm per one to two hours as tolerated. Once the dose reaches 5 ppm, weaning is accomplished in 1 ppm per hour decrements until iNO is discontinued. Signs that weaning is progressing too quickly include an increasing oxygen requirement or signs of RV failure (increasing central venous pressure, increasing pulmonary artery pressures and decreasing cardiac output or blood pressure). An alternative agent used in some institutions is inhaled <a class="drug drug_general" data-topicid="9411" href="/d/drug information/9411.html" rel="external">epoprostenol</a> administered at 0.01 to 0.05 mcg/kg/minute via jet nebulizer, with dose adjustments based on efficacy and tolerability of side effects (eg, hypotension, nausea and vomiting). (See  <a class="medical medical_review" href="/d/html/4663.html" rel="external">"Primary lung graft dysfunction", section on 'Treatment'</a>.)</p><p>ECMO may be necessary in patients with severe refractory hypoxia and/or hypercapnia and consequent RV failure [<a href="#rid10">10</a>]. VV ECMO is usually preferred in those who not require hemodynamic support since lower levels of anticoagulation are needed compared with VA ECMO, with lower risk of complications such as bleeding or stroke [<a href="#rid19">19,66,67</a>]. However, patients with pulmonary arterial hypertension or severe PGD may require VA ECMO to provide the most effective offloading and protection of the transplanted lungs. (See <a class="local">'Mechanical cardiorespiratory support'</a> above.)</p><p class="headingAnchor" id="H335742568"><span class="h2">Emergence and timing of extubation</span><span class="headingEndMark"> — </span>At the conclusion of surgery, the DLT is exchanged for a single-lumen endotracheal tube. If airway management was challenging initially, an airway exchange catheter is used, particularly if ventilation and oxygenation are compromised at the conclusion of surgery. However, caution is advised to avoid airway trauma during insertion of an airway exchange catheter [<a href="#rid68">68</a>]. A flexible tip catheter may help to avoid this complication.</p><p>We do not routinely extubate patients in the OR because risk for reintubation may be higher compared with later extubation in the ICU, and benefits are uncertain [<a href="#rid5">5,69-71</a>]. However, some centers have developed protocols to facilitate extubation in the OR at the end of the procedure in selected patients [<a href="#rid69">69-72</a>]. Candidates for such early extubation include patients with low intraoperative transfusion requirements [<a href="#rid70">70</a>], minimal or absent episodes of intraoperative hemodynamic instability, no need for ECMO [<a href="#rid69">69,70</a>], and those with previously established epidural analgesia [<a href="#rid69">69-72</a>].</p><p>For patients on VV ECMO who have adequate oxygenation following lung transplantation, removal of ECMO cannula is often accomplished at the end of the operation.</p><p>Ideally, patients are weaned and extubated within 24 hours of surgery to reduce stress on bronchial anastomoses and decrease risk for pulmonary infection [<a href="#rid19">19</a>]. Splinting and rapid shallow breathing due to pain predispose to development of atelectasis. In particular, pulmonary mechanics are impaired after a clamshell incision, with marked reductions in postoperative forced expiratory volume (FEV<sub>1</sub>) and vital capacity [<a href="#rid73">73</a>]. In addition, patients with a denervated lung have decreased cough reflex and decreased ability to clear secretions. For these reasons, some patients may need support with controlled postoperative mechanical ventilation for one to two days after lung transplantation surgery to allow time to achieve optimal pain control and pulmonary mechanics [<a href="#rid74">74</a>].</p><p class="headingAnchor" id="H2266958951"><span class="h1">POSTOPERATIVE ANALGESIA</span><span class="headingEndMark"> — </span>Providing effective postoperative analgesia after lung transplantation is critical to facilitate recovery, although no consensus exists regarding an optimal approach. Similar to other operations requiring thoracotomy, continuous thoracic epidural analgesia (TEA) or paravertebral block (PVB) are the most commonly employed techniques to control pain [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Post-thoracotomy pain management'</a>.)</p><p class="headingAnchor" id="H2978026952"><span class="h2">Challenges in pain control</span><span class="headingEndMark"> — </span>Pain after lung transplantation, particularly if performed via a clamshell incision or a large thoracotomy incision, may be severe. TEA or PVB for postoperative analgesia may be less effective compared with other procedures (see  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Thoracic epidural analgesia'</a> and  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Paravertebral block'</a>) [<a href="#rid73">73,75</a>]. Furthermore, if a TEA catheter or bilateral PVB catheters are placed in the preoperative period, intraoperative administration of local anesthetic may result in a sympathectomy with vasodilation and hypotension, causing difficulty in maintaining a restrictive fluid management strategy (see  <a class="medical medical_review" href="/d/html/89517.html" rel="external">"Overview of neuraxial anesthesia", section on 'Cardiovascular'</a> and <a class="local">'Fluid and transfusion management'</a> above). For this reason, initiation of a local anesthetic infusion is generally deferred until the surgical procedure has been completed. Local anesthetics may be added to the continuous infusion for the TEA or PVB catheter in the intensive care unit (ICU), after the patient is no longer receiving general anesthetic agents, thereby avoiding the risk of additive or synergistic effects that may cause hypotension.</p><p>Optimal pain control is also challenging because administration of local anesthetic agents via an epidural catheter may result in a sympathectomy that can lead to hemodynamic instability in a fluid-restricted patient (see  <a class="medical medical_review" href="/d/html/89517.html" rel="external">"Overview of neuraxial anesthesia", section on 'Cardiovascular'</a>), although this may be less likely with unilateral paravertebral block (see  <a class="medical medical_review" href="/d/html/126309.html" rel="external">"Thoracic paravertebral block procedure guide"</a>). Furthermore, systemic administration of intravenous (IV) opioid agents, typically via patient-controlled analgesia (PCA), may result in hypotension, as well as oversedation and hypercarbia (see  <a class="medical medical_review" href="/d/html/134254.html" rel="external">"Use of opioids for postoperative pain control", section on 'Opioid side effects and complications'</a>). In addition, use of nonsteroidal anti-inflammatory drugs (NSAIDs) is typically avoided due to concern for increasing the risk of acute kidney injury in a fluid-restricted patient. (See  <a class="medical medical_review" href="/d/html/133187.html" rel="external">"Nonopioid pharmacotherapy for acute pain in adults", section on 'Nonsteroidal anti-inflammatory drugs'</a>.)</p><p class="headingAnchor" id="H2078389205"><span class="h2">Neuraxial and regional techniques</span></p><p class="headingAnchor" id="H330561144"><span class="h3">Thoracic epidural analgesia</span><span class="headingEndMark"> — </span>We typically place a TEA catheter in the postoperative (rather than the preoperative) period because of concerns regarding development of an epidural hematoma if intraoperative systemic anticoagulation is necessary for cardiopulmonary bypass (CPB) or extracorporeal membrane oxygenation (ECMO). Patients are individually assessed by our acute pain service for epidural placement within 24 to 48 hours of transplantation. Institution-specific and patient-specific considerations determine whether timing is before or after tracheal extubation [<a href="#rid74">74,76</a>]. (See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Thoracic epidural analgesia'</a>.)</p><p>In a retrospective review of more than 150 patients, preoperative placement of a TEA catheter was associated with significantly decreased postoperative opioid use and duration of controlled mechanical ventilation, compared with postoperative catheter placement [<a href="#rid74">74</a>]. However, earlier placement was not associated with reduced length of stay in the ICU or hospital. In another retrospective review of more than 100 patients, preoperative TEA catheter placement resulted in slightly better postoperative pain scores but no differences in pulmonary complications compared with postoperative placement [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H3638817167"><span class="h3">Paravertebral block</span><span class="headingEndMark"> — </span>Compared with TEA, catheter-based PVB with administration of a continuous infusion of local anesthetic agents to provide analgesia after thoracotomy or clamshell incision provides comparable analgesia and may be associated with fewer adverse side effects, particularly with unilateral PVB [<a href="#rid17">17,78-83</a>]. (See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Choice of technique'</a> and  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Paravertebral block'</a> and  <a class="medical medical_review" href="/d/html/126309.html" rel="external">"Thoracic paravertebral block procedure guide"</a>.)</p><p>A PVB catheter may be placed by either the anesthesiologist [<a href="#rid84">84</a>] or the surgeon [<a href="#rid85">85</a>]. Direct placement by the surgeon at the conclusion of the procedure has the advantage of appropriate timing after reversal of anticoagulation, thereby minimizing risk for hematoma. An advantage for PVB catheter placement after single lung transplantation is that unilateral catheter placement preserves function of the contralateral intercostal muscles and nerves [<a href="#rid85">85,86</a>].</p><p class="headingAnchor" id="H1822613339"><span class="h3">Serratus anterior plane block</span><span class="headingEndMark"> — </span>Case reports have described successful pain control using bilateral serratus anterior plane block catheters inserted after bilateral lung transplantation [<a href="#rid17">17,87,88</a>].</p><p class="headingAnchor" id="H3163422985"><span class="h2">Systemic analgesics</span><span class="headingEndMark"> — </span>A short-acting opioid (typically <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a>) is administered to provide analgesia before leaving the operating room (OR), and a fentanyl infusion is initiated on arrival to the ICU as part of a sedation regimen while the patient remains intubated. In preparation for extubation, nurse-administered <a class="drug drug_general" data-topicid="8538" href="/d/drug information/8538.html" rel="external">hydromorphone</a> boluses are administered as needed, with a transition to hydromorphone PCA after extubation. Nonopioid analgesics are often added to reduce opioid requirements. (See  <a class="medical medical_review" href="/d/html/133187.html" rel="external">"Nonopioid pharmacotherapy for acute pain in adults"</a> and  <a class="medical medical_review" href="/d/html/134254.html" rel="external">"Use of opioids for postoperative pain control"</a>.)</p><p class="headingAnchor" id="H3854431004"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical approaches</strong> (See <a class="local">'Overview of surgical techniques'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Single lung transplantation is accomplished in lateral position via a standard posterolateral or anterolateral thoracotomy incision. One lung ventilation (OLV) of the nonoperative lung is required unless full cardiopulmonary bypass (CPB) support has been established. During OLV, some patients require partial mechanical cardiorespiratory support with venoarterial (VA) or venovenous (VV) extracorporeal membrane oxygenation (ECMO).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bilateral lung transplantation is accomplished as two separate but sequential transplants, typically in supine position via a transverse thoracosternotomy (ie, clamshell) incision. The native lung with the worst function is replaced first while OLV is used for the contralateral lung. Following a brief period of dual lung ventilation and reperfusion of the first lung allograft, OLV is switched to the opposite side for transplantation of the second lung. Problems with hypoxemia or hemodynamic instability may necessitate ECMO or full CPB support.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring</strong> – Transesophageal echocardiography (TEE) is used to monitor intravascular volume status and left and right ventricular (RV) function, guide ECMO cannula placement, and assess post-transplant pulmonary artery (PA) and pulmonary vein (PV) anastomoses. (See <a class="local">'Monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anticoagulation</strong> – Anticoagulation is required for lung transplantation; heparin dosing depends on whether the procedure is performed off-pump (with or without VA or VV ECMO support) or with full CPB support. (See <a class="local">'Anticoagulation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Induction of general anesthesia</strong> – For patients with aspiration risk factors, we perform rapid sequence induction and intubation (RSII); in such patients, we suggest <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> as the anesthetic induction agent especially if hemodynamic instability is anticipated (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>).</p><p></p><p class="bulletIndent1">For patients without aspiration risk, we suggest a slower induction technique (eg, low doses of short-acting benzodiazepine, synthetic opioid, and anesthetic induction agent) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Induction of general anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Endotracheal tube management</strong> – A double-lumen endotracheal tube (DLT) is typically used to facilitate OLV. During single lung transplantation, a left-sided DLT is selected for right pneumonectomy  (<a class="graphic graphic_figure graphicRef88677" href="/d/graphic/88677.html" rel="external">figure 5</a>); a right-sided DLT is selected for left pneumonectomy  (<a class="graphic graphic_figure graphicRef88676" href="/d/graphic/88676.html" rel="external">figure 6</a>). For bilateral lung transplantation, a left-sided DLT is usually selected, with the bronchial cuff positioned as far proximally as possible to allow room for the anastomosis. (See <a class="local">'Lung isolation'</a> above.)</p><p></p><p class="bulletIndent1">At the conclusion of surgery, the DLT is exchanged for a single-lumen endotracheal tube. Weaning and extubation should occur within 24 hours of surgery to reduce stress on bronchial anastomoses and decrease risk for pulmonary infection. (See <a class="local">'Emergence and timing of extubation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pretransplantation ventilator settings</strong> – After intubation, lung-protective, low tidal volume (TV) ventilation is initiated at approximately 6 mL/kg for two lung ventilation, then decreased to approximately 4 to 5 mL/kg for OLV. Positive end-expiratory pressure (PEEP) is initially set at 5 to 10 cm H<sub>2</sub>O with plateau inspiratory pressure target &lt;25 to 30 cm H<sub>2</sub>O. Respiratory rate is adjusted to maintain the end-tidal carbon dioxide (ETCO<sub>2</sub>) and partial pressure of carbon dioxide (PaCO<sub>2</sub>) near baseline. Fraction of inspired oxygen (FiO<sub>2</sub>) is adjusted to maintain pulse oxygen saturation (SpO<sub>2</sub>) at 89 to 95 percent. (See <a class="local">'Ventilation before transplantation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraoperative fluid and hemodynamic support</strong> – We use a restrictive fluid management strategy, similar to other open thoracotomy procedures. (See <a class="local">'Fluid and transfusion management'</a> above.)</p><p></p><p class="bulletIndent1">Hypotension is common during lung transplant procedures, particularly during clamping of the PA, partial clamping of the left atrium to complete the PV anastomoses, and/or reperfusion of the lung. We suggest using <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> as the first-line vasopressor agent (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). If hypotension persists, we add or substitute <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a> to further increase systemic vascular resistance (SVR) with little effect on pulmonary vascular resistance (PVR)  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 1</a>). In patients with severe RV dysfunction or failure, we typically add or substitute <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">dobutamine</a>, or <a class="drug drug_general" data-topicid="9652" href="/d/drug information/9652.html" rel="external">milrinone</a>. (See <a class="local">'Hemodynamic management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanical cardiorespiratory support</strong> – Refractory hypoxemia and/or hypotension necessitates ECMO (VV or VA) or CPB in approximately 20 to 40 percent of lung transplant recipients. We suggest using ECMO rather than CPB when possible (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). ECMO is associated with lower rates of primary graft dysfunction (PGD), need for dialysis, tracheostomy, and blood transfusion, and shorter intubation time and hospital stay. However, full CPB is necessary for some patients (eg, those requiring an additional cardiac surgical procedure). (See <a class="local">'Mechanical cardiorespiratory support'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Post-transplantation ventilator settings</strong> – After reperfusion and inflation of the transplanted lung(s), with lung recruitment breaths as needed, lung-protective ventilation is established with low TV (eg, 6 mL/kg) and other ventilator settings similar to pretransplantation settings. PEEP is typically set at low levels (5 to 10 cm<sub> </sub>H<sub>2</sub>O). FiO<sub>2</sub> is set at the lowest level that maintains SpO<sub>2</sub> at 92 percent. If FiO<sub>2</sub> &gt;50 percent is necessary, additional recruitment maneuvers, small increases in PEEP, bronchodilator administration, and/or airway suctioning are employed. (See <a class="local">'Ventilation after lung transplantation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary graft dysfunction after reperfusion</strong> – PGD should be suspected in patients with refractory hypoxemia (low PaO<sub>2</sub>/FiO<sub>2</sub> ratio) after inflation and reperfusion of the allograft(s) and exclusion of other sources of poor oxygenation (eg, mucous plugging, cardiogenic pulmonary edema, occlusion of a pulmonary venous anastomosis, pulmonary thromboembolism).</p><p></p><p class="bulletIndent1">We suggest a trial of <a class="drug drug_general" data-topicid="9447" href="/d/drug information/9447.html" rel="external">inhaled nitric oxide</a> (iNO) for patients with refractory hypoxemia after optimizing ventilator settings and intravascular volume status (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>), typically at 10 to 20 parts per million (ppm). We start iNO at 20 ppm if arterial oxygen tension (PaO<sub>2</sub>)/FiO<sub>2</sub> is &lt;100, and wean the dose as oxygenation improves. An alternative is inhaled <a class="drug drug_general" data-topicid="9411" href="/d/drug information/9411.html" rel="external">epoprostenol</a> administered via jet nebulizer at 0.01 to 0.05 mcg/kg per minute. (See <a class="local">'Primary graft dysfunction after reperfusion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative pain management</strong> – We place a thoracic epidural analgesia (TEA) catheter or unilateral or bilateral paravertebral block (PVB) catheters.</p><p></p><p class="bulletIndent1">We suggest deferring initiation of local anesthetic infusion until completion of the surgical procedure (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Intraoperative administration may result in sympathectomy with vasodilation and hypotension. Additionally, administration of systemic opioids via patient-controlled analgesia (PCA) is typically required. (See <a class="local">'Postoperative analgesia'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Martin AK, Renew JR, Jayaraman AL, et al. Analysis of Outcomes in Lung Transplantation. J Cardiothorac Vasc Anesth 2019; 33:1455.</a></li><li><a class="nounderline abstract_t">Rao P, Khalpey Z, Smith R, et al. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest. Circ Heart Fail 2018; 11:e004905.</a></li><li><a class="nounderline abstract_t">Cevasco M, Takayama H, Ando M, et al. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation. J Thorac Dis 2019; 11:1676.</a></li><li><a class="nounderline abstract_t">Cakici M, Gumus F, Ozcinar E, et al. Controlled flow diversion in hybrid venoarterial-venous extracorporeal membrane oxygenation. Interact Cardiovasc Thorac Surg 2018; 26:112.</a></li><li><a class="nounderline abstract_t">McGlothlin DP, Granton J, Klepetko W, et al. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. J Heart Lung Transplant 2022; 41:1135.</a></li><li><a class="nounderline abstract_t">Lee AJ, Huffmyer JL, Thiele EL, et al. The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists. Anesth Analg 2022; 134:1245.</a></li><li><a class="nounderline abstract_t">Hayanga JW, D'Cunha J. The surgical technique of bilateral sequential lung transplantation. J Thorac Dis 2014; 6:1063.</a></li><li><a class="nounderline abstract_t">Marczin N, de Waal EEC, Hopkins PMA, et al. International consensus recommendations for anesthetic and intensive care management of lung transplantation. A EACTAIC, SCA, ISHL, EOT, ESTS, and AST approved document. J Heart Lung Transplant 2021; 40.</a></li><li><a class="nounderline abstract_t">Mizota T, Matsukawa S, Fukagawa H, et al. Preoperative Hypercapnia as a Predictor of Hypotension During Anesthetic Induction in Lung Transplant Recipients. J Cardiothorac Vasc Anesth 2015; 29:967.</a></li><li><a class="nounderline abstract_t">Rana M, Yusuff H, Zochios V. The Right Ventricle During Selective Lung Ventilation for Thoracic Surgery. J Cardiothorac Vasc Anesth 2019; 33:2007.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112:1084.</a></li><li><a class="nounderline abstract_t">Evans A, Dwarakanath S, Hogue C, et al. Intraoperative echocardiography for patients undergoing lung transplantation. Anesth Analg 2014; 118:725.</a></li><li><a class="nounderline abstract_t">Tomasi R, Betz D, Schlager S, et al. Intraoperative Anesthetic Management of Lung Transplantation: Center-Specific Practices and Geographic and Centers Size Differences. J Cardiothorac Vasc Anesth 2018; 32:62.</a></li><li><a class="nounderline abstract_t">Serra E, Feltracco P, Barbieri S, et al. Transesophageal echocardiography during lung transplantation. Transplant Proc 2007; 39:1981.</a></li><li><a class="nounderline abstract_t">Hertel T, Banayan JM, Chaney MA, et al. Systolic Anterior Motion of the Mitral Valve With Left Ventricular Outflow Tract Obstruction: A Rare Cause of Hypotension After Lung Transplantation. J Cardiothorac Vasc Anesth 2017; 31:1894.</a></li><li><a class="nounderline abstract_t">Tan Z, Roscoe A, Rubino A. Transesophageal Echocardiography in Heart and Lung Transplantation. J Cardiothorac Vasc Anesth 2019; 33:1548.</a></li><li><a class="nounderline abstract_t">Martin AK, Yalamuri SM, Wilkey BJ, et al. The Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation. J Cardiothorac Vasc Anesth 2020; 34:1669.</a></li><li><a class="nounderline abstract_t">Yamaguchi CT, Moody AE, Beutler BD, Lee JP. Severe Pulmonary Hypertension and Septum Left Shift. Anesthesiology 2023; 139:326.</a></li><li><a class="nounderline abstract_t">Moreno Garijo J, Cypel M, McRae K, et al. The Evolving Role of Extracorporeal Membrane Oxygenation in Lung Transplantation: Implications for Anesthetic Management. J Cardiothorac Vasc Anesth 2019; 33:1995.</a></li><li><a class="nounderline abstract_t">González-Fernández C, González-Castro A, Rodríguez-Borregán JC, et al. Pulmonary venous obstruction after lung transplantation. Diagnostic advantages of transesophageal echocardiography. Clin Transplant 2009; 23:975.</a></li><li><a class="nounderline abstract_t">Abrams BA, Melnyk V, Allen WL, et al. TEE for Lung Transplantation: A Case Series and Discussion of Vascular Complications. J Cardiothorac Vasc Anesth 2020; 34:733.</a></li><li><a class="nounderline abstract_t">Wakefield BJ, Alfirevic A. Pulmonary Venous Flow After Lung Transplantation: Turbulence and High Velocities. J Cardiothorac Vasc Anesth 2020; 34:1985.</a></li><li><a class="nounderline abstract_t">Soto RG, Oleszak SP. Resection of the Arndt Bronchial Blocker during stapler resection of the left lower lobe. J Cardiothorac Vasc Anesth 2006; 20:131.</a></li><li><a class="nounderline abstract_t">Kiely DG, Cargill RI, Lipworth BJ. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996; 109:1215.</a></li><li><a class="nounderline abstract_t">Bermudez CA, Shiose A, Esper SA, et al. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation. Ann Thorac Surg 2014; 98:1936.</a></li><li><a class="nounderline abstract_t">Ius F, Sommer W, Tudorache I, et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results. J Heart Lung Transplant 2016; 35:49.</a></li><li><a class="nounderline abstract_t">Machuca TN, Collaud S, Mercier O, et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg 2015; 149:1152.</a></li><li><a class="nounderline abstract_t">Burdett C, Butt T, Lordan J, et al. Comparison of single lung transplant with and without the use of cardiopulmonary bypass. Interact Cardiovasc Thorac Surg 2012; 15:432.</a></li><li><a class="nounderline abstract_t">Bittner HB, Binner C, Lehmann S, et al. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg 2007; 31:462.</a></li><li><a class="nounderline abstract_t">Martin AK, Jayaraman AL, Nabzdyk CG, et al. Extracorporeal Membrane Oxygenation in Lung Transplantation: Analysis of Techniques and Outcomes. J Cardiothorac Vasc Anesth 2021; 35:644.</a></li><li><a class="nounderline abstract_t">Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis. Gen Thorac Cardiovasc Surg 2018; 66:38.</a></li><li><a class="nounderline abstract_t">Fierro MA, Daneshmand MA, Bartz RR. Perioperative Management of the Adult Patient on Venovenous Extracorporeal Membrane Oxygenation Requiring Noncardiac Surgery. Anesthesiology 2018; 128:181.</a></li><li><a class="nounderline abstract_t">Hirose H, Yamane K, Marhefka G, Cavarocchi N. Right ventricular rupture and tamponade caused by malposition of the Avalon cannula for venovenous extracorporeal membrane oxygenation. J Cardiothorac Surg 2012; 7:36.</a></li><li><a class="nounderline abstract_t">Sladen RN. New Innovations in Circulatory Support With Ventricular Assist Device and Extracorporeal Membrane Oxygenation Therapy. Anesth Analg 2017; 124:1071.</a></li><li><a class="nounderline abstract_t">Nam KH, Koh Y, Lim CM, et al. Central Extracorporeal Membrane Oxygenation for Bridging of Right-Sided Heart Failure to Lung Transplantation: A Single-Center Experience and Literature Review. J Cardiothorac Vasc Anesth 2019; 33:1873.</a></li><li><a class="nounderline abstract_t">Glorion M, Mercier O, Mitilian D, et al. Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension. Eur J Cardiothorac Surg 2018; 54:341.</a></li><li><a class="nounderline abstract_t">Sklar MC, Sy E, Lequier L, et al. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review. Ann Am Thorac Soc 2016; 13:2242.</a></li><li><a class="nounderline abstract_t">McIlroy DR, Pilcher DV, Snell GI. Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis. Br J Anaesth 2009; 102:506.</a></li><li><a class="nounderline abstract_t">Assaad S, Kratzert WB, Perrino AC Jr. Extravascular lung water monitoring for thoracic and lung transplant surgeries. Curr Opin Anaesthesiol 2019; 32:29.</a></li><li><a class="nounderline abstract_t">Geube MA, Perez-Protto SE, McGrath TL, et al. Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation. Anesth Analg 2016; 122:1081.</a></li><li><a class="nounderline abstract_t">Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187:527.</a></li><li><a class="nounderline abstract_t">Cernak V, Oude Lansink-Hartgring A, van den Heuvel ER, et al. Incidence of Massive Transfusion and Overall Transfusion Requirements During Lung Transplantation Over a 25-Year Period. J Cardiothorac Vasc Anesth 2019; 33:2478.</a></li><li><a class="nounderline abstract_t">Huddleston SJ, Jackson S, Kane K, et al. Separate Effect of Perioperative Recombinant Human Factor VIIa Administration and Packed Red Blood Cell Transfusions on Midterm Survival in Lung Transplantation Recipients. J Cardiothorac Vasc Anesth 2020; 34:3013.</a></li><li><a class="nounderline abstract_t">Seay T, Guinn N, Maisonave Y, et al. The Association of Increased FFP:RBC Transfusion Ratio to Primary Graft Dysfunction in Bleeding Lung Transplantation Patients. J Cardiothorac Vasc Anesth 2020; 34:3024.</a></li><li><a class="nounderline abstract_t">Lam S, Mofidi S, Saddic L, et al. Incidence of Intraoperative Vasoplegic Syndrome in Lung Transplantation. J Cardiothorac Vasc Anesth 2023; 37:2531.</a></li><li><a class="nounderline abstract_t">Siehr SL, Feinstein JA, Yang W, et al. Hemodynamic Effects of Phenylephrine, Vasopressin, and Epinephrine in Children With Pulmonary Hypertension: A Pilot Study. Pediatr Crit Care Med 2016; 17:428.</a></li><li><a class="nounderline abstract_t">Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial. Anesthesiology 2017; 126:85.</a></li><li><a class="nounderline abstract_t">Khan TA, Schnickel G, Ross D, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 2009; 138:1417.</a></li><li><a class="nounderline abstract_t">Bhatt AM, Stein EJ. Clinical Complications with the Delivery of Inhaled Epoprostenol in the Operating Room. Anesthesiology 2017; 127:383.</a></li><li><a class="nounderline abstract_t">Kim N, Lee SH, Joe Y, et al. Effects of Inhaled Iloprost on Lung Mechanics and Myocardial Function During One-Lung Ventilation in Chronic Obstructive Pulmonary Disease Patients Combined With Poor Lung Oxygenation. Anesth Analg 2020; 130:1407.</a></li><li><a class="nounderline abstract_t">Ghadimi K, Cappiello J, Cooter-Wright M, et al. Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial. JAMA Surg 2022; 157:e215856.</a></li><li><a class="nounderline abstract_t">Bhandary S, Stoicea N, Joseph N, et al. Pro: Inhaled Pulmonary Vasodilators Should Be Used Routinely in the Management of Patients Undergoing Lung Transplantation. J Cardiothorac Vasc Anesth 2017; 31:1123.</a></li><li><a class="nounderline abstract_t">Ramadan ME, Shabsigh M, Awad H. Con: Inhaled Pulmonary Vasodilators Are Not Indicated in Patients Undergoing Lung Transplantation. J Cardiothorac Vasc Anesth 2017; 31:1127.</a></li><li><a class="nounderline abstract_t">Fessler J, Godement M, Pirracchio R, et al. Inhaled nitric oxide dependency at the end of double-lung transplantation: a boosted propensity score cohort analysis. Transpl Int 2019; 32:244.</a></li><li><a class="nounderline abstract_t">Barnes L, Reed RM, Parekh KR, et al. MECHANICAL VENTILATION FOR THE LUNG TRANSPLANT RECIPIENT. Curr Pulmonol Rep 2015; 4:88.</a></li><li><a class="nounderline abstract_t">Di Nardo M, Tikkanen J, Husain S, et al. Postoperative Management of Lung Transplant Recipients in the Intensive Care Unit. Anesthesiology 2022; 136:482.</a></li><li><a class="nounderline abstract_t">Diamond JM, Arcasoy S, Kennedy CC, et al. Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017; 36:1104.</a></li><li><a class="nounderline abstract_t">Verbeek GL, Myles PS. Intraoperative protective ventilation strategies in lung transplantation. Transplant Rev (Orlando) 2013; 27:30.</a></li><li><a class="nounderline abstract_t">Weill D, Torres F, Hodges TN, et al. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant 1999; 18:1080.</a></li><li><a class="nounderline abstract_t">Rai HS, Boehm JK, Stoller JK. Biphasic capnogram in a single-lung transplant recipient: a case report. Respir Care 2014; 59:E108.</a></li><li><a class="nounderline abstract_t">Srinivasa V, Kodali BS, Hartigan PM. Evolving capnograms after single lung transplant. Anesth Analg 2004; 98:1504.</a></li><li><a class="nounderline abstract_t">Mitchell JB, Shaw AD, Donald S, Farrimond JG. Differential lung ventilation after single-lung transplantation for emphysema. J Cardiothorac Vasc Anesth 2002; 16:459.</a></li><li><a class="nounderline abstract_t">Verbeek GL, Myles PS, Westall GP, et al. Intra-operative protective mechanical ventilation in lung transplantation: a randomised, controlled trial. Anaesthesia 2017; 72:993.</a></li><li><a class="nounderline abstract_t">Snell GI, Yusen RD, Weill D, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017; 36:1097.</a></li><li><a class="nounderline abstract_t">Shargall Y, Guenther G, Ahya VN, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. J Heart Lung Transplant 2005; 24:1489.</a></li><li><a class="nounderline abstract_t">Van Raemdonck D, Hartwig MG, Hertz MI, et al. Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017; 36:1121.</a></li><li><a class="nounderline abstract_t">Ruberto F, Bergantino B, Testa MC, et al. Low-flow venovenous CO₂ removal in association with lung protective ventilation strategy in patients who develop severe progressive respiratory acidosis after lung transplantation. Transplant Proc 2013; 45:2741.</a></li><li><a class="nounderline abstract_t">McLean S, Lanam CR, Benedict W, et al. Airway exchange failure and complications with the use of the Cook Airway Exchange Catheter®: a single center cohort study of 1177 patients. Anesth Analg 2013; 117:1325.</a></li><li><a class="nounderline abstract_t">Assenzo V, Assenzo C, Filippo R, et al. The feasibility of extubation in the operating room after bilateral lung transplantation in adult emphysema patients: an observational retrospective study. Eur J Cardiothorac Surg 2018; 54:1128.</a></li><li><a class="nounderline abstract_t">Felten ML, Moyer JD, Dreyfus JF, et al. Immediate postoperative extubation in bilateral lung transplantation: predictive factors and outcomes. Br J Anaesth 2016; 116:847.</a></li><li><a class="nounderline abstract_t">Hansen LN, Ravn JB, Yndgaard S. Early extubation after single-lung transplantation: analysis of the first 106 cases. J Cardiothorac Vasc Anesth 2003; 17:36.</a></li><li><a class="nounderline abstract_t">Augoustides JG, Watcha SM, Pochettino A, Jobes DR. Early tracheal extubation in adults undergoing single-lung transplantation for chronic obstructive pulmonary disease: pilot evaluation of perioperative outcome. Interact Cardiovasc Thorac Surg 2008; 7:755.</a></li><li><a class="nounderline abstract_t">Macchiarini P, Ladurie FL, Cerrina J, et al. Clamshell or sternotomy for double lung or heart-lung transplantation? Eur J Cardiothorac Surg 1999; 15:333.</a></li><li><a class="nounderline abstract_t">McLean SR, von Homeyer P, Cheng A, et al. Assessing the Benefits of Preoperative Thoracic Epidural Placement for Lung Transplantation. J Cardiothorac Vasc Anesth 2018; 32:2654.</a></li><li><a class="nounderline abstract_t">Richard C, Girard F, Ferraro P, et al. Acute postoperative pain in lung transplant recipients. Ann Thorac Surg 2004; 77:1951.</a></li><li><a class="nounderline abstract_t">Cason M, Naik A, Grimm JC, et al. The efficacy and safety of epidural-based analgesia in a case series of patients undergoing lung transplantation. J Cardiothorac Vasc Anesth 2015; 29:126.</a></li><li><a class="nounderline abstract_t">Axtell AL, Heng EE, Fiedler AG, et al. Pain management and safety profiles after preoperative vs postoperative thoracic epidural insertion for bilateral lung transplantation. Clin Transplant 2018; 32:e13445.</a></li><li><a class="nounderline abstract_t">Yeung JH, Gates S, Naidu BV, et al. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev 2016; 2:CD009121.</a></li><li><a class="nounderline abstract_t">Joshi GP, Bonnet F, Shah R, et al. A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg 2008; 107:1026.</a></li><li><a class="nounderline abstract_t">Romero A, Garcia JE, Joshi GP. The state of the art in preventing postthoracotomy pain. Semin Thorac Cardiovasc Surg 2013; 25:116.</a></li><li><a class="nounderline abstract_t">Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials. Br J Anaesth 2006; 96:418.</a></li><li><a class="nounderline abstract_t">Ding X, Jin S, Niu X, et al. A comparison of the analgesia efficacy and side effects of paravertebral compared with epidural blockade for thoracotomy: an updated meta-analysis. PLoS One 2014; 9:e96233.</a></li><li><a class="nounderline abstract_t">D'Ercole F, Arora H, Kumar PA. Paravertebral Block for Thoracic Surgery. J Cardiothorac Vasc Anesth 2018; 32:915.</a></li><li><a class="nounderline abstract_t">Hutchins J, Apostolidou I, Shumway S, et al. Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study. J Cardiothorac Vasc Anesth 2017; 31:142.</a></li><li><a class="nounderline abstract_t">Lenz N, Hirschburger M, Roehrig R, et al. Application of Continuous Wound-Infusion Catheters in Lung Transplantation: A Retrospective Data Analysis. Thorac Cardiovasc Surg 2017; 65:403.</a></li><li><a class="nounderline abstract_t">Gelzinis TA. An Update on Postoperative Analgesia Following Lung Transplantation. J Cardiothorac Vasc Anesth 2018; 32:2662.</a></li><li><a class="nounderline abstract_t">Anderson AJ, Marciniak D. Bilateral Serratus Anterior Plane (SAP) Catheters: ANovel Approach to Promote Postoperative Recovery After Bilateral Sequential Lung Transplantation. J Cardiothorac Vasc Anesth 2019; 33:1353.</a></li><li><a class="nounderline abstract_t">Sekandarzad MW, Konstantatos A, Donovan S. Bilateral Continuous Serratus Anterior Blockade for Postoperative Analgesia After Bilateral Sequential Lung Transplantation. J Cardiothorac Vasc Anesth 2019; 33:1356.</a></li></ol></div><div id="topicVersionRevision">Topic 118937 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30072266" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Analysis of Outcomes in Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30354364" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31179113" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29155934" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Controlled flow diversion in hybrid venoarterial-venous extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36123001" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35020677" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25132973" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The surgical technique of bilateral sequential lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : International consensus recommendations for anesthetic and intensive care management of lung transplantation. A EACTAIC, SCA, ISHL, EOT, ESTS, and AST approved document</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25649696" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Preoperative Hypercapnia as a Predictor of Hypotension During Anesthetic Induction in Lung Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30595486" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The Right Ventricle During Selective Lung Ventilation for Thoracic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20418689" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24651226" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Intraoperative echocardiography for patients undergoing lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29174123" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intraoperative Anesthetic Management of Lung Transplantation: Center-Specific Practices and Geographic and Centers Size Differences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17692671" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Transesophageal echocardiography during lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28648775" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Systolic Anterior Motion of the Mitral Valve With Left Ventricular Outflow Tract Obstruction: A Rare Cause of Hypotension After Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30709594" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Transesophageal Echocardiography in Heart and Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31623969" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37437099" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Severe Pulmonary Hypertension and Septum Left Shift.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30455142" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The Evolving Role of Extracorporeal Membrane Oxygenation in Lung Transplantation: Implications for Anesthetic Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19732099" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Pulmonary venous obstruction after lung transplantation. Diagnostic advantages of transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31570240" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : TEE for Lung Transplantation: A Case Series and Discussion of Vascular Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32144057" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pulmonary Venous Flow After Lung Transplantation: Turbulence and High Velocities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16458238" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Resection of the Arndt Bronchial Blocker during stapler resection of the left lower lobe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8625670" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25443002" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26496786" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25583107" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22714587" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Comparison of single lung transplant with and without the use of cardiopulmonary bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17188884" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32546408" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Extracorporeal Membrane Oxygenation in Lung Transplantation: Analysis of Techniques and Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28918471" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28984630" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Perioperative Management of the Adult Patient on Venovenous Extracorporeal Membrane Oxygenation Requiring Noncardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22515939" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Right ventricular rupture and tamponade caused by malposition of the Avalon cannula for venovenous extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27984228" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : New Innovations in Circulatory Support With Ventricular Assist Device and Extracorporeal Membrane Oxygenation Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30898420" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Central Extracorporeal Membrane Oxygenation for Bridging of Right-Sided Heart Failure to Lung Transplantation: A Single-Center Experience and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29528384" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27690525" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19224927" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30507676" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Extravascular lung water monitoring for thoracic and lung transplant surgeries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26991618" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23306540" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clinical risk factors for primary graft dysfunction after lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31147209" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Incidence of Massive Transfusion and Overall Transfusion Requirements During Lung Transplantation Over a 25-Year Period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32718888" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Separate Effect of Perioperative Recombinant Human Factor VIIa Administration and Packed Red Blood Cell Transfusions on Midterm Survival in Lung Transplantation Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32622711" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The Association of Increased FFP:RBC Transfusion Ratio to Primary Graft Dysfunction in Bleeding Lung Transplantation Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37775341" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Incidence of Intraoperative Vasoplegic Syndrome in Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27144689" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hemodynamic Effects of Phenylephrine, Vasopressin, and Epinephrine in Children With Pulmonary Hypertension: A Pilot Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27841822" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19931670" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28323647" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinical Complications with the Delivery of Inhaled Epoprostenol in the Operating Room.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32167976" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effects of Inhaled Iloprost on Lung Mechanics and Myocardial Function During One-Lung Ventilation in Chronic Obstructive Pulmonary Disease Patients Combined With Poor Lung Oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34787647" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27863877" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pro: Inhaled Pulmonary Vasodilators Should Be Used Routinely in the Management of Patients Undergoing Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27856154" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Con: Inhaled Pulmonary Vasodilators Are Not Indicated in Patients Undergoing Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30449027" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Inhaled nitric oxide dependency at the end of double-lung transplantation: a boosted propensity score cohort analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26495241" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : MECHANICAL VENTILATION FOR THE LUNG TRANSPLANT RECIPIENT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34910811" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Postoperative Management of Lung Transplant Recipients in the Intensive Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28802530" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23394883" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Intraoperative protective ventilation strategies in lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598731" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24327741" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Biphasic capnogram in a single-lung transplant recipient: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15105248" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Evolving capnograms after single lung transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12154426" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Differential lung ventilation after single-lung transplantation for emphysema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28695586" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Intra-operative protective mechanical ventilation in lung transplantation: a randomised, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28942784" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210120" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28784325" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24034037" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Low-flow venovenous CO₂removal in association with lung protective ventilation strategy in patients who develop severe progressive respiratory acidosis after lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24257382" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Airway exchange failure and complications with the use of the Cook Airway Exchange Catheter®: a single center cohort study of 1177 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29800126" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The feasibility of extubation in the operating room after bilateral lung transplantation in adult emphysema patients: an observational retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27199316" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Immediate postoperative extubation in bilateral lung transplantation: predictive factors and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635058" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Early extubation after single-lung transplantation: analysis of the first 106 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18628342" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Early tracheal extubation in adults undergoing single-lung transplantation for chronic obstructive pulmonary disease: pilot evaluation of perioperative outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10333032" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Clamshell or sternotomy for double lung or heart-lung transplantation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29754733" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Assessing the Benefits of Preoperative Thoracic Epidural Placement for Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15172243" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Acute postoperative pain in lung transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25440655" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The efficacy and safety of epidural-based analgesia in a case series of patients undergoing lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30412311" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Pain management and safety profiles after preoperative vs postoperative thoracic epidural insertion for bilateral lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26897642" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Paravertebral block versus thoracic epidural for patients undergoing thoracotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18713924" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24216528" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The state of the art in preventing postthoracotomy pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16476698" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24797238" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A comparison of the analgesia efficacy and side effects of paravertebral compared with epidural blockade for thoracotomy: an updated meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29169795" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Paravertebral Block for Thoracic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27543993" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27043787" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Application of Continuous Wound-Infusion Catheters in Lung Transplantation: A Retrospective Data Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29935804" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : An Update on Postoperative Analgesia Following Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30174262" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Bilateral Serratus Anterior Plane (SAP) Catheters: ANovel Approach to Promote Postoperative Recovery After Bilateral Sequential Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30174264" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Bilateral Continuous Serratus Anterior Blockade for Postoperative Analgesia After Bilateral Sequential Lung Transplantation.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
